本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Artelo Biosciences, Inc.

13.73
-0.0300-0.22%
盘后13.730.00000.00%19:21 EDT
成交量:3.97万
成交额:54.62万
市值:967.18万
市盈率:-0.76
高:14.27
开:14.18
低:13.30
收:13.76
数据加载中...
2025/07/18

重要事件披露

Form 8-K - Current report
2025/07/11

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/07/11

重要事件披露

Form 8-K - Current report
2025/06/26

重要事件披露

Form 8-K - Current report
2025/06/13

重要事件披露

Form 8-K - Current report
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/04/29

重要事件披露

Form 8-K - Current report
2025/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/17

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]